Clinical Trial Update: HRV as a Marker of Treatment Response in PAH Arterial Hypertension

View source ↗

Summary

A completed clinical trial evaluating whether heart rate variability can serve as a biomarker for treatment response in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Cincinnati | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED